Text this: A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies

 ______    __   __    _____     ______   _    _   
|      \\  \ \\/ //  / ____||  /_   _// | || | || 
|  --  //   \ ` //  / //---`'   -| ||-  | || | || 
|  --  \\    | ||   \ \\___     _| ||_  | \\_/ || 
|______//    |_||    \_____||  /_____//  \____//  
`------`     `-`'     `----`   `-----`    `---`